Correlation Between Ever Supreme and GeneReach Biotechnology

Can any of the company-specific risk be diversified away by investing in both Ever Supreme and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ever Supreme and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ever Supreme Bio and GeneReach Biotechnology, you can compare the effects of market volatilities on Ever Supreme and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ever Supreme with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ever Supreme and GeneReach Biotechnology.

Diversification Opportunities for Ever Supreme and GeneReach Biotechnology

0.77

Correlation Coefficient

Ever Supreme  GeneReach Biotechnology

Poor diversification

The 3 months correlation between Ever and GeneReach is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Ever Supreme Bio and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Ever Supreme is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ever Supreme Bio are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Ever Supreme i.e., Ever Supreme and GeneReach Biotechnology go up and down completely randomly.

Pair Corralation between Ever Supreme and GeneReach Biotechnology

Assuming the 90 days trading horizon Ever Supreme Bio is expected to generate 0.73 times more return on investment than GeneReach Biotechnology. However, Ever Supreme Bio is 1.37 times less risky than GeneReach Biotechnology. It trades about -0.05 of its potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.08 per unit of risk. If you would invest  19,750  in Ever Supreme Bio on September 30, 2024 and sell it today you would lose (2,050) from holding Ever Supreme Bio or give up 10.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Ever Supreme Bio  vs.  GeneReach Biotechnology

Ever Supreme Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ever Supreme Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Ever Supreme is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, GeneReach Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Ever Supreme and GeneReach Biotechnology

The main advantage of trading using opposite Ever Supreme and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ever Supreme position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.

The idea behind Ever Supreme Bio and GeneReach Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.